Lamberto Andreotti has been designated the next chief executive officer of Bristol-Myers Squibb. On May 4, James M. Cornelius will retire from that role, but will retain his title of chairman. In March 2009, Mr. Andreotti was named president and chief operating officer and is responsible for the global pharmaceutical business. Mr. Andreotti has been with BMS for 12 years in senior leadership roles, both internationally and in the U.S. Prior to joining the company, he held senior roles at KABI...